These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30246473)

  • 1. Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis.
    McGurnaghan S; Blackbourn LAK; Mocevic E; Haagen Panton U; McCrimmon RJ; Sattar N; Wild S; Colhoun HM
    Diabet Med; 2019 Jun; 36(6):718-725. PubMed ID: 30246473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socio-economic differences in cardiovascular disease risk factor prevalence in people with type 2 diabetes in Scotland: a cross-sectional study.
    Whittaker E; Read SH; Colhoun HM; Lindsay RS; McGurnaghan S; McKnight JA; Sattar N; Wild SH;
    Diabet Med; 2020 Aug; 37(8):1395-1402. PubMed ID: 32189372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register.
    Read SH; van Diepen M; Colhoun HM; Halbesma N; Lindsay RS; McKnight JA; McAllister DA; Pearson ER; Petrie JR; Philip S; Sattar N; Woodward M; Wild SH;
    Diabetes Care; 2018 Sep; 41(9):2010-2018. PubMed ID: 30002197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry.
    Shah VN; Bailey R; Wu M; Foster NC; Pop-Busui R; Katz M; Crandall J; Bacha F; Nadeau K; Libman I; Hiers P; Mizokami-Stout K; DiMeglio LA; Sherr J; Pratley R; Agarwal S; Snell-Bergeon J; Cengiz E; Polsky S; Mehta SN
    J Clin Endocrinol Metab; 2020 May; 105(5):e2032-8. PubMed ID: 31955209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).
    Ito H; Harano Y; Suzuki M; Hattori Y; Takeuchi M; Inada H; Inoue J; Kawamori R; Murase T; Ouchi Y; Umeda F; Nawata H; Orimo H
    Diabetes; 1996 Jul; 45 Suppl 3():S19-23. PubMed ID: 8674883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shortened Relative Leukocyte Telomere Length Is Associated With Prevalent and Incident Cardiovascular Complications in Type 2 Diabetes: Analysis From the Hong Kong Diabetes Register.
    Cheng F; Luk AO; Tam CHT; Fan B; Wu H; Yang A; Lau ESH; Ng ACW; Lim CKP; Lee HM; Chow E; Kong AP; Keech AC; Joglekar MV; So WY; Jenkins AJ; Chan JCN; Hardikar AA; Ma RCW
    Diabetes Care; 2020 Sep; 43(9):2257-2265. PubMed ID: 32661111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint and distinct risk factors associated with micro- and macrovascular complications in a cohort of type 2 diabetic patients cared through disease management.
    Ciardullo AV; Daghio MM; Bevini M; Feltri G; Novi D; Fattori G; Borsari S; Donato CD
    Acta Diabetol; 2010 Dec; 47(4):301-8. PubMed ID: 20383650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in cardiovascular risk factors before and after the development of type 2 diabetes and risk for incident cardiovascular disease.
    Bancks MP; Akhabue E; Rana JS; Reis JP; Schreiner PJ; Yano Y; Lewis CE
    Diabetes Res Clin Pract; 2020 Aug; 166():108334. PubMed ID: 32702469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of silent myocardial ischaemia prevalence and cardiovascular disease risk factor management in Type 2 diabetes over a 10-year period: an observational study.
    Sultan A; Perriard F; Macioce V; Mariano-Goulart D; Boegner C; Daures JP; Avignon A
    Diabet Med; 2017 Sep; 34(9):1244-1251. PubMed ID: 28419565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic disorders associated with uncontrolled hypertension.
    Bøg-Hansen E; Lindblad U; Gullberg B; Melander A; Råstam L
    Diabetes Obes Metab; 2003 Nov; 5(6):379-87. PubMed ID: 14617223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
    Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
    Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and predictors for cardiovascular disease in Chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
    Wan EY; Fong DY; Fung CS; Lam CL
    J Diabetes Complications; 2016 Apr; 30(3):444-50. PubMed ID: 26774791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of deprivation on cardiovascular risk factors in people with diabetes: an observational study.
    Wild S; Macleod F; McKnight J; Watt G; Mackenzie C; Ford I; McConnachie A; Lindsay RS
    Diabet Med; 2008 Feb; 25(2):194-9. PubMed ID: 18290861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease and Mortality in Individuals With Type 2 Diabetes.
    Hanssen NMJ; Westerink J; Scheijen JLJM; van der Graaf Y; Stehouwer CDA; Schalkwijk CG;
    Diabetes Care; 2018 Aug; 41(8):1689-1695. PubMed ID: 29784769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride, albuminuria and blood pressure are the major associations of non-fatal cardiovascular disease in Chinese type 2 diabetes.
    Ko GT; Chan JC; Chow CC; Yeung VT; Chan WB; So WY; Ma RC; Ozaki R; Cockram CS
    Acta Diabetol; 2003 Jun; 40(2):80-4. PubMed ID: 12861405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early onset type 2 diabetes mellitus: a harbinger for complications in later years--clinical observation from a secondary care cohort.
    Song SH; Hardisty CA
    QJM; 2009 Nov; 102(11):799-806. PubMed ID: 19734298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study.
    Ferrara A; Mangione CM; Kim C; Marrero DG; Curb D; Stevens M; Selby JV;
    Diabetes Care; 2008 Jan; 31(1):69-74. PubMed ID: 17934157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications.
    J Hypertens; 1993 Mar; 11(3):309-17. PubMed ID: 8387089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relevance of diabetes in high cardiovascular risk hypertensive patients].
    Segura J; de la Sierra A; Fernández S; Ruilope LM;
    Med Clin (Barc); 2013 Oct; 141(7):287-91. PubMed ID: 22841470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.